Tilvestamab [2226775-26-2]

TargetMol Chemicals

Tilvestamab

9

2226775-26-2

Antibody

Research Use Only

Tilvestamab

Tilvestamab (BGB149), a humanized anti-AXL antibody, effectively blocks AXL-mediated cell signaling, significantly reduces Gas6-induced AXL activation, and inhibits downstream AKT phosphorylation in 786-0-Luc RCC cells. This compound is particularly useful in cancer research focusing on renal cell carcinomas with overexpressed AXL [1].

3 years

-20°C

12352203